Skip to main content
OpenTrials

Clinical trial condition

Immune System Diseases

Explore clinical trials studying Immune System Diseases. Study availability and eligibility vary by location and protocol.

318 public trials 57 recruiting studies
Refine in advanced search Browse all conditions

Immune System Diseases trial results

Recruiting

A Study of the Safety and Activity of Sparsentan for the Treatment of Patients With Immunoglobulin A Nephropathy

NCT04663204

Conditions
Autoimmune Diseases, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations
  • Cambridge University Hospitals NHS Trust Cambridge, England, United Kingdom
  • Northern Care Alliance NHS Foundation Trust - Salford Royal Salford, England, United Kingdom
  • Royal Infirmary of Edinburgh & Western General Hospital Edinburgh, Scotland, United Kingdom
  • University Hospital of wales Cardiff, Wales, United Kingdom
View Trial Details
Recruiting

A Study of Treatment of Inflammation Before Stem Cell Transplant in People With a Primary Immune Regulatory Disorder (PIRD) and/or an Autoinflammatory Condition

NCT05787574

Conditions
Autoimmune Lymphoproliferative, Immune System Diseases, Primary Immune Regulatory Disorder
Locations
  • University of California, San Francisco San Francisco, California, United States
  • Children's Healthcare of Atlanta Atlanta, Georgia, United States
  • Memorial Sloan Kettering Basking Ridge Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth Middletown, New Jersey, United States
View all 13 locations
View Trial Details
Recruiting

Reduced Intensity Conditioning and Familial HLA-Mismatched BMT for Non-Malignant Disorders

NCT03128996

Conditions
Anemia, Anemia, Hemolytic, Anemia, Hemolytic, Congenital, +16 more
Locations
  • Yale School of Medicine New Haven, Connecticut, United States
  • Nemours Children's Health Wilmington, Delaware, United States
  • Helen DeVos Children's Hospital Grand Rapids, Michigan, United States
  • Washington University School of Medicine St Louis, Missouri, United States
View Trial Details
Recruiting

A Phase 1/2, Open-label, Safety and Dosing Study of Autologous CART Cells (Desmoglein 3 Chimeric Autoantibody Receptor T Cells [DSG3-CAART] or CD19-specific Chimeric Antigen Receptor T Cells [CABA-201]) in Subjects With Active, Pemphigus Vulgaris (RESET-PV)

NCT04422912

Conditions
Autoimmune Diseases, Immune System Diseases, Pemphigus, +4 more
Locations
  • Stanford University, Dept. of Dermatology Redwood City, California, United States
  • UC Davis, Dept. of Dermatology Sacramento, California, United States
  • Yale University New Haven, Connecticut, United States
  • Northwestern University Chicago, Illinois, United States
View all 13 locations
View Trial Details
Recruiting

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

NCT05826535

Conditions
Disease Attributes, Hemic and Lymphatic Diseases, Immune System Diseases, +17 more
Locations
  • University of California-Irvine Medical Center Irvine, California, United States
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • University of California, Los Angeles (UCLA) Medical Center Los Angeles, California, United States
  • Scripps Clinic San Diego, California, United States
View all 34 locations
View Trial Details
Recruiting

A Study to Evaluate the Efficacy and Safety of IMG-007 in Adult Participants With Moderate-to-Severe Atopic Dermatitis

NCT07037901

Conditions
Atopic Dermatitis, Atopic Dermatitis Eczema, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +11 more
Locations
  • Inmagene Site 1 Lancaster, California, United States
  • Inmagene Site 23 Los Angeles, California, United States
  • Inmagene Site 19 Ocala, Florida, United States
  • Inmagene Site 4 Tampa, Florida, United States
View all 23 locations
View Trial Details
Recruiting

Natural History of Type 1 Interferonopathies: Insights From a European Cohort

NCT07040774

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Disease, +5 more
Locations
  • Medical University Innsbruck Innsbruck, Austria
  • Antwerp University Hospital Antwerp, Belgium
  • Children's Hospital Zagreb Zagreb, Croatia
  • Motol University Hospital Prague, Czechia
View all 32 locations
View Trial Details
Recruiting

(Apex) Bezuclastinib in Patients With Advanced Systemic Mastocytosis

NCT04996875

Conditions
Advanced Systemic Mastocytosis (AdvSM), Aggressive Systemic Mastocytosis (ASM), Bone Marrow Diseases, +35 more
Locations
  • University of Alabama at Birmingham (UAB) Hospital Birmingham, Alabama, United States
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • City of Hope Comprehensive Cancer Center Duarte, California, United States
  • UCLA Medical Center Los Angeles, California, United States
View all 42 locations
View Trial Details
Recruiting

CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)

NCT03328078

Conditions
Disease Attributes, Hematologic Diseases, Hematologic Neoplasms, +17 more
Locations
  • St. Joseph's Hospital and Medical Center Phoenix, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • City of Hope Duarte, California, United States
  • Providence St. John's Health Center Santa Monica, California, United States
View all 45 locations
View Trial Details

Related conditions